Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
36.59
+1.75 (5.02%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
36.59
-0.00 (-0.00%)
Bozordan keyin: Jun 26, 2026, 4:31 PM EDT
Collegium Pharmaceutical, Inc., ixtisoslashtirilgan farmatsevtika kompaniyasi, og'riqni boshqarish uchun dori vositalarini ishlab chiqish va tijoratlashtirish bilan shug'ullanadi. Kompaniya portfeliga diqqat etishmovchiligi giperfaollik buzilishi (DEHB) ni davolash uchun metilfenidat HCl ni o'z ichiga olgan markaziy asab tizimini rag'batlantiruvchi dori vositasi bo'lgan Jornay PM; uzoq muddat davomida davolashni talab qiladigan kuchli va doimiy og'riqni davolash uchun buprenorfinni o'z ichiga olgan bukkal plyonka bo'lgan Belbuka; kundalik davolashni talab qiladigan kuchli og'riqni boshqarish uchun oksikodonning suiiste'molga chidamli, uzaytirilgan chiqariladigan, og'iz orqali qabul qilinadigan shakli bo'lgan Xtampza ER; o'tkir, kuchli va doimiy og'riqni boshqarish uchun ko'rsatilgan tapentadolning uzaytirilgan va darhol chiqariladigan, og'iz orqali qabul qilinadigan shakllari bo'lgan Nucynta ER va Nucynta IR; va surunkali rak bo'lmagan og'riq bilan og'rigan kattalardagi bemorlarda opioid bilan bog'liq ich qotishini davolash uchun naldemedine ning og'iz orqali qabul qilinadigan shakli bo'lgan Symproic kiradi. Collegium Pharmaceutical, Inc. ilgari Collegium Pharmaceuticals, Inc. nomi bilan tanilgan va 2003 yil oktyabr oyida Collegium Pharmaceutical, Inc. nomiga o'zgargan. Kompaniya 2002 yilda ro'yxatga olingan va shtab-kvartirasi Massachusets shtatining Stoughton shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Thomas B. Smith FAAFP, M.D. | Executive VP & Chief Medical Officer |
| Mr. David Dieter | Executive VP, General Counsel & Corporate Secretary |
| Mr. Dean J. Patras | Chief People Officer |
| Mr. Ian Karp M.B.A. | Head of Investor Relations |
| Mr. Scott Sudduth | EVP & Head of Technical Operations |
| Mr. Vikram Karnani | CEO, President & Director |
| Ms. Colleen Tupper | Executive VP & CFO |
| Ms. Jane Gonnerman | Executive Vice President of Strategy & Corporate Development |
| Ms. Jessica Cotrone | Senior Vice President of Communications & Corporate Affairs |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-01 | S-8 | tm2615914d1_s8.htm |
| 2026-05-15 | 8-K | tm2614189d1_8k.htm |
| 2026-05-12 | 8-K | tm2614189d1_8k.htm |
| 2026-05-07 | 8-K | coll-20260507.htm |
| 2026-04-07 | DEF 14A | coll-20260407.htm |
| 2026-04-07 | ARS | tm269886d2_ars.pdf |
| 2026-03-19 | 8-K | tm269336d1_8k.htm |
| 2026-02-26 | 8-K | coll-20260226.htm |
| 2026-02-26 | 10-K | coll-20251231.htm |
| 2026-01-08 | 8-K | tm262493d1_8k.htm |